MLTX vs. ASST
MLTX (MoonLake Immunotherapeutics) and ASST (Asset Entities Inc. Class B Common Stock) are both stocks. MLTX operates in Biotechnology (Healthcare), while ASST operates in Internet Content & Information (Communication Services). Over the past 3 years, MLTX returned -13.16%/yr vs -47.18%/yr for ASST. At a 0.07 correlation, their price movements are largely independent.
Performance
MLTX vs. ASST - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, MLTX achieves a 38.62% return, which is significantly higher than ASST's -0.14% return.
MLTX
- 1D
- 2.24%
- 1M
- 4.04%
- YTD
- 38.62%
- 6M
- 36.85%
- 1Y
- -62.37%
- 3Y*
- -13.16%
- 5Y*
- 12.70%
- 10Y*
- —
ASST
- 1D
- -8.56%
- 1M
- -9.87%
- YTD
- -0.14%
- 6M
- -29.81%
- 1Y
- -89.47%
- 3Y*
- -47.18%
- 5Y*
- —
- 10Y*
- —
MLTX vs. ASST - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | |
|---|---|---|---|---|
MLTX MoonLake Immunotherapeutics | 38.62% | -75.66% | -10.33% | 401.16% |
ASST Asset Entities Inc. Class B Common Stock | -0.14% | 50.46% | -84.65% | -82.00% |
Correlation
The correlation between MLTX and ASST is 0.16, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.16 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.09 |
Correlation (All Time) Calculated using the full available price history since Feb 6, 2023 | 0.07 |
Fundamentals
MLTX:
$1.30B
ASST:
$908.43M
MLTX:
-$3.90
ASST:
-$25.54
MLTX:
$0.00
ASST:
$5.73M
MLTX:
-$1.49M
ASST:
-$7.43M
MLTX:
-$179.84M
ASST:
-$304.63M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
MLTX vs. ASST — Risk / Return Rank
MLTX
ASST
MLTX vs. ASST - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for MoonLake Immunotherapeutics (MLTX) and Asset Entities Inc. Class B Common Stock (ASST). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| MLTX | ASST | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | 0.00 | ||
| Sortino ratioReturn per unit of downside risk | +1.63 | ||
| Omega ratioGain probability vs. loss probability | 1.17 | 0.90 | +0.27 |
| Calmar ratioReturn relative to maximum drawdown | -0.70 | -0.93 | +0.24 |
| Martin ratioReturn relative to average drawdown | -0.99 | -1.15 | +0.16 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| MLTX | ASST | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.54 | -0.54 | 0.00 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.14 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.12 | -0.19 | +0.31 |
Drawdowns
MLTX vs. ASST - Drawdown Comparison
The maximum MLTX drawdown since its inception was -90.22%, smaller than the maximum ASST drawdown of -97.98%. Use the drawdown chart below to compare losses from any high point for MLTX and ASST.
Loading charts...
Drawdown Indicators
| MLTX | ASST | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -90.22% | -97.98% | +7.76% |
Max Drawdown (1Y)Largest decline over 1 year | -89.93% | -95.98% | +6.05% |
Max Drawdown (3Y)Largest decline over 3 years | -90.22% | -97.25% | +7.03% |
Max Drawdown (5Y)Largest decline over 5 years | -90.22% | — | — |
Current DrawdownCurrent decline from peak | -71.39% | -95.85% | +24.46% |
Average DrawdownAverage peak-to-trough decline | -29.15% | -84.09% | +54.94% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 62.80% | 77.76% | -14.96% |
Volatility
MLTX vs. ASST - Volatility Comparison
The current volatility for MoonLake Immunotherapeutics (MLTX) is 18.88%, while Asset Entities Inc. Class B Common Stock (ASST) has a volatility of 23.94%. This indicates that MLTX experiences smaller price fluctuations and is considered to be less risky than ASST based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| MLTX | ASST | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 18.88% | 23.94% | -5.06% |
Volatility (6M)Calculated over the trailing 6-month period | 56.83% | 81.76% | -24.93% |
Volatility (1Y)Calculated over the trailing 1-year period | 117.11% | 165.43% | -48.32% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 91.12% | 323.23% | -232.11% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 86.52% | 323.23% | -236.71% |
Dividends
MLTX vs. ASST - Dividend Comparison
Neither MLTX nor ASST has paid dividends to shareholders.
Financials
MLTX vs. ASST - Financials Comparison
This section allows you to compare key financial metrics between MoonLake Immunotherapeutics and Asset Entities Inc. Class B Common Stock. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
MLTX and ASST have a correlation of 0.16, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ASST has higher volatility (23.94%) compared to MLTX (18.88%). In terms of maximum drawdown, MLTX dropped -90.22% vs ASST's -97.98%.
MLTX currently has the higher Sharpe Ratio (-0.54 vs -0.54), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for MLTX and ASST
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer